AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04897074 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AKL-T01
Description: AKL-T01 multitasking digital treatment. AKL-T01 multitasking treatment employs perceptual discrimination attention/memory task as well as a continuous motor driving task.
Study NCT05355168 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery
Description: neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery
Study NCT06114992 — intervention group
Intervention type: DEVICE
Intervention: Servo-n HFOV modes
Description: Treatment with high frequency oscillatory ventilation with Servo-n device in accordance to Standard of Care
Study NCT05678400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypopressive abdominal techniques
Description: Both training protocols were carried out in a single intervention for each of the participants assigned to either the HAT or the PNF stretching group. The intervention began with the measurement of hip flexion using the EPR test, and ended with a post-intervention measurement of hip flexion to observe the effects of the treatment. All measurements, as well as the interventions for each of the patients in the two groups, were carried out by the same registered physiotherapist. In order to standardise an order of examination of the lower limbs in the EPR test, the right lower limb was assessed first, followed by the left lower limb. Likewise, the same order was standardised for stretching in the PNF group.
Study NCT05678400 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stretching of proprioceptive neuromuscular facilitation
Description: Stretching of proprioceptive neuromuscular facilitation
Study NCT05160623 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eyelid cleansing wipes
Description: EYECARE FORTE eyelid wipes (Dr. Fischer, Israel), used to clean the lids and lashes once daily
Study NCT06524869 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Isokinetic neuromuscular assessment
Description: All sports patients who had a muscle evaluation in addition to functional testing at 6-12 months after ACLR since March 2024
Study NCT06309160 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COMPASS Across Settings (CAST)
Description: CAST will begin with an initial joint session with the student, caregiver, special education teacher, and pre-employment transition specialist that allows for discussion on the student's postsecondary goals, preferences, frustrations, challenges, and strengths related to social skills, adaptive/self-management, communication, problem behaviors, learning skills, and sensory sensitivities and preferences. This discussion will pinpoint critical social, communication, and work behavior/learning goals related to postsecondary goals and inform the intervention plans that are generated for each goal. Following this initial consultation, there will be four additional 1-hour sessions that incorporate evidence-based coaching, provided by the investigators, including performance feedback monitoring and instructional support. Each session is standardized and allows for assessment of student progress and intervention modification/self-reflection on the implementation of the intervention plans.
Study NCT06309160 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: COMPASS Across Settings (CAST)
Description: CAST will begin with an initial joint session with the student, caregiver, special education teacher, and pre-employment transition specialist that allows for discussion on the student's postsecondary goals, preferences, frustrations, challenges, and strengths related to social skills, adaptive/self-management, communication, problem behaviors, learning skills, and sensory sensitivities and preferences. This discussion will pinpoint critical social, communication, and work behavior/learning goals related to postsecondary goals and inform the intervention plans that are generated for each goal. Following this initial consultation, there will be four additional 1-hour sessions that incorporate evidence-based coaching, provided by the investigators, including performance feedback monitoring and instructional support. Each session is standardized and allows for assessment of student progress and intervention modification/self-reflection on the implementation of the intervention plans.
Study NCT06130514 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: Ultrasound-guided stellate ganglion block with 1% mepivacaine 5 mL
Study NCT06130514 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fluoroscopy
Description: Fluoroscopic-guided thoracic sympathetic ganglion block with 1% mepivacaine 3 mL
Study NCT05063292 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patients in Group II will receive active prewarming with an air forced blanket (full body blanket) 30 minutes prior to the operation
Description: Core temperature and 4-points skin temperatures measurements will be recorded all over the operation. Patients will be delivered 2 Litre/minute oxygen with a nasal cannula.Iv hydration will be continued by room temperatured balanced electrolyte solution with an infusion rate of 2mL/kg/hr. Spinal anesthesia will be applied at the level of L3-L4 by a 25 Gauge Quincke needle with a dose of 12.5-15 mg hyperbaric bupivacaine in the sitting position.
Study NCT05879822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB099280
Description: Administered as specified in the treatment arm description
Study NCT06047678 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiovascular fitness
Description: A randomized single-blind controlled trial tested the hypothesis that different variants of resistance training (antagonistic lower and upper body training, agonistic lower and upper body training, and aerobic training) have different effects on blood pressure (systolic and diastolic), aortic pulse wave velocity (PWVao), and augmentation index (Aix) values and compared subjects with normotension and hypertension during and after exercise session.
Study NCT06093672 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Givinostat
Description: Oral.
Study NCT06093672 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxyurea
Description: Oral.
Study NCT05430607 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Running therapy
Description: A 9-week running program.
Study NCT04973423 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: MRI
Description: 2 additional MRI will be done for the CALM + MRI group
Study NCT06530940 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Buccal Schirmer Test
Description: For each group, we will perform:~* SF measurement~* Buccal Schirmer test (BST) .
Study NCT06499038 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total Hip Arthroplasty
Description: Surgery for total hip replacement
Study NCT06499038 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Hip Arthroplasty
Description: Surgery for total hip replacement
Study NCT04950348 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Personalized TKA prosthesis
Description: TKA prosthesis that is designed and manufactured according to the patient's knee joint anatomy
Study NCT04950348 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Zimmer NexGen prostheses
Description: Commercial products used on a large scale
Study NCT06409338 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcutaneous auricular vagus nerve stimulation (active）
Description: Transcutaneous auricular vagus nerve stimulation was conducted by transcutaneous electrical stimulation therapy instrument to the cymba conchae of left ear in the vicinity of the auricular branch vagus nerve. Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs, twice a day, 30 minutes each time.
Study NCT06409338 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous auricular vagus nerve stimulation (sham）
Description: In the sham stimulation group, the electrodes were fixed at the left earlobe with the same stimulus parameters. Stimulation parameters: frequency = 20 Hz; pulse width = 500 μs, twice a day, 30 minutes each time.
Study NCT04946435 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Antibiotic Irrigation
Description: The first 30 patients will be assigned to the control group to collect data on common nasal packing colonization and appropriate antibiotic selection for the experimental group. The following 30 patients will be assigned to the experimental group. Immediately following surgery, the control group will receive nasal packing alone and the experimental group will receive nasal packing with antibiotic irrigation
Study NCT04946435 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic Irrigation
Description: The first 30 patients will be assigned to the control group to collect data on common nasal packing colonization and appropriate antibiotic selection for the experimental group. The following 30 patients will be assigned to the experimental group. Immediately following surgery, the control group will receive nasal packing alone and the experimental group will receive nasal packing with antibiotic irrigation
Study NCT06539156 — intervention group
Intervention type: OTHER
Intervention: DVT prophyllaxis
Description: VTE prophylaxis administration among patients based on the American College of Chest Physicians (ACCP) recommendations
Study NCT06182124 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Multivalent Pneumococcal Vaccine - Formulation 1
Description: Multivalent pneumococcal conjugate vaccine. This is a possible candidate for continuation in Phase 2 (Stage 2) and Phase 2(Stage 3).
Study NCT06182124 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Multivalent Pneumococcal Vaccine - Formulation 2
Description: Multivalent pneumococcal conjugate vaccine. This is a possible candidate for continuation in Phase 2 (Stage 2) and Phase 2(Stage 3).
Study NCT06182124 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 20-valent pneumococcal conjugate vaccine (20vPnC)
Description: 20-valent pneumococcal conjugate vaccine (20vPnC)
Study NCT06182124 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Licensed pneumococcal comparator vaccine
Description: A licensed pneumococcal comparator vaccine
Study NCT06436833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2-Liter polyethylene glycol plus elobixibat
Description: Take Elobixibat 10 mg, one day before colonoscopy at 8 a.m. Take Polyethylene glycol 1 Liter, one day before colonoscopy at 8 p.m. Take polyethylene glycol 1 Liter, at day of colonoscopy at 5 a.m.
Study NCT06436833 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 4-Liter polyethylene glycol
Description: Take Polyethylene glycol 2 Liter, one day before colonoscopy at 8 p.m. Take polyethylene glycol 2 Liter, at day of colonoscopy at 5 a.m.
Study NCT05190991 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RPH-104
Description: solution for subcutaneous administration 40 mg/mL, 2 mL in the 4-mL glass vial
Study NCT05103904 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT05103904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Given PO
Study NCT06489743 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 6-minute walk test (6MWT)
Description: 6-minute walk test (6MWT) will be performed according to clinical standards
Study NCT06489743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Description: 6-minute walk test (6MWT) will be performed according to clinical standards
Study NCT05441696 — intervention group
Intervention type: DEVICE
Intervention: ezCVP measurement
Description: * Measuring device: non-FDA-cleared patient monitor (740E, Zoe Medical, MA, US), which has software to measure ezCVP.~* Sensor: an FDA-cleared pulse oximeter sensor for adults (K012891: DS-100A, Nellcor, CA, US).~* Cuff: an FDA-cleared NIBP cuff for adults (K080342: YP-713T, YP-714T or TP-715T, Nihon Kohden Corporation, Tokyo, Japan).
Study NCT05986175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Imagery Training
Description: The motor imagery training will be given with an audio recording containing 15 minutes of motor imagery training. The protocol will be administered by a physiotherapist 3 times a week for 8 weeks.
Study NCT05986175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core Stabilization Exercises
Description: Jeffreys' Core (body) Stabilization Exercises will be implemented. The protocol consists of exercises that progress gradually from the first level to the third level. The first level consists of static contraction training on a stable surface; the second level is dynamic training on stable surfaces; and the third level is dynamic and resistant training on an unstable surface. Each session is scheduled to last 45 minutes, with 5 minutes of heating and 5 minutes of cooling exercises. The protocol will be administered by a physiotherapist 3 times a week for 8 weeks.
Study NCT05986175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stabilization Exercises
Description: Jeffreys' Core (body) Stabilization Exercises will be implemented. The protocol consists of exercises that progress gradually from the first level to the third level. The first level consists of static contraction training on a stable surface; the second level is dynamic training on stable surfaces; and the third level is dynamic and resistant training on an unstable surface. Each session is scheduled to last 45 minutes, with 5 minutes of heating and 5 minutes of cooling exercises. The protocol will be administered by a physiotherapist 3 times a week for 8 weeks.
Study NCT05355974 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Description: Norepinephrine continuous infusion at 0.10 mcg/kg/min
Study NCT05355974 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactated Ringers, Intravenous
Description: 500mL infusion run at 999mL/hr
Study NCT05355974 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactated Ringers, Intravenous
Description: 500mL infusion run at 999mL/hr
Study NCT05355974 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: normal saline
Description: 500mL infusion run at 999mL/hr
Study NCT05355974 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: normal saline
Description: 500mL infusion run at 999mL/hr
Study NCT05355974 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Plasma-lyte
Description: 500mL infusion run at 999mL/hr
Study NCT05355974 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plasma-lyte
Description: 500mL infusion run at 999mL/hr
Study NCT05959122 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CBC serum iron serum ferritin
Description: 1. Fully automated blood cell counter (sysmex-Xs 800i) and AU 480-Chemistry auto-analyzer (Beckman Coulter Diagnostics-USA) was used for measurement of hemoglobin and serum iron levels~2. Chemiluminescence assay using an Abbott i2000SR analyser was used to measured serum ferritin
Study NCT04162431 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: spectroscopic measurement
Description: measurement of the tissue with spectroscopy
Study NCT04879901 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: surface EMG
Description: surface EMG estimation with Carrying backpacks forward or backward
Study NCT05455099 — intervention group
Intervention type: RADIATION
Intervention: Carotid ultrasound examination 1
Description: Participants will be assigned to obese group (body mass index 24.0-27.9 kg/m²). Carotid pulse wave velocity of all participants were measured by ultrafast ultrasound imaging technology using SuperSonic Imagine's explorer ultrasound system.
Study NCT05455099 — intervention group
Intervention type: RADIATION
Intervention: Carotid ultrasound examination 2
Description: Based on the inclusion criteria, 1200 overweight Han people（body mass index ≥28.0 kg/m²） and both sexes will be recruited in the analysis. The values of ultrafast pulse wave velocity will be obtained.
Study NCT06272630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWJ1464
Description: DWJ1464, TID, Duration of administration: 8 weeks, Visit: every 4 week
Study NCT06272630 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of DWJ1464
Description: Placebo of DWJ1464, TID, Duration of administration: 8 weeks, Visit: every 4 week
Study NCT05712902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunvozertinib
Description: Daily dose of Sunvozertinib
Study NCT05003531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI112 dose 2
Description: Participants will receive placebo or dose 2 IBI112 SC
Study NCT05003531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI112 dose 4
Description: Participants will receive placebo or dose 4 IBI112 SC
Study NCT05003531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI112 dose 1
Description: Participants will receive placebo or dose 1 IBI112 SC
Study NCT05003531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI112 dose 3
Description: Participants will receive placebo or dose 3 IBI112 SC
Study NCT05003531 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Participants will receive placebo SC
Study NCT04850846 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin XR
Description: Orally by mouth
Study NCT04850846 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Orally by mouth
Study NCT06482034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine
Description: N-acetyl cysteine sachets
Study NCT06482034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Description: zinc sulfate capsules
Study NCT04162431 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FNA biopsy
Description: a fine needle aspiration (FNA) biopsy will be taken
Study NCT04162431 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: histopathology and cytology
Description: Histopathology and cytology will be performed on the samples
Study NCT06207097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physiotherapy techniques
Description: Dry neeling: invasive physiotherapy technique where an acupuncture needle is used on painful points Elastic taping: physiotherapy technique where elastic bandage is used on the skin Exercise program: physical exercise prescription
Study NCT06218537 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Test group
Description: Contains protease from KREON capsules, activated by adding sodium bicarbonate.
Study NCT06482034 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: saline mouth wash
Description: saline mouth wash
Study NCT06236022 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: at a dose of 2 mg once daily
Study NCT05403866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LT3001 Drug Product
Description: Administered by intravenous infusion
Study NCT05403866 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered by intravenous infusion
Study NCT05881616 — intervention group
Intervention type: OTHER
Intervention: Specimen samples and baseline data collection
Description: The remaining serum samples from routine blood tests of subjects will be collected (without additional blood collection), with a serum sample size of approximately 1 mL per subject. The samples will be pre-processed and stored at ultra-low temperatures. At the same time, clinical baseline data of subjects will be collected from outpatient or inpatient medical records, including but not limited to age, height, weight, blood pressure, and gestational age.
Study NCT06218537 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: Contains only sodium bicarbonate.
Study NCT04657588 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Navina anal insert
Description: The Navina anal device is a single-use, pre-lubricated, liquid-filled rectal insert with a plastic applicator. The insert is filled with liquid mineral oil. The primary advantage of this new instrument is the fact that the liquid-filled insert will move and adapt as the fluid is transferred throughout the device making it easy to insert/remove and comfortable to wear. The design is intended to adjust to the contours of the individual anatomy to prevent leakage.
Study NCT04657588 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Care as usual
Description: Care as usual means participants are to continue their usual treatment for FI, like they would if they would not have participated in this study.
Study NCT06501378 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1/PD-L1 inhibitor plus chemotherapy
Description: Active brain metastases patients will receive PD-L1/PD-1 inhibitors and chemotherapy.
Study NCT06501378 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SRT/WBRT
Description: Active brain metastases (BM) patients will receive stereotactic radiotherapy (SRT) and whole brain radiation therapy (WBRT) according to their BM condition.
Study NCT03674320 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Testosterone Enanthate
Description: Testosterone Enanthate (25 mg women, 100mg men) will be given via intramuscular injection at study week 2, 3, 6, 7, 10 and 11.
Study NCT03674320 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Injection (saline) will be given via intramuscular injection at study week 2, 3, 6, 7, 10 and 11.